Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12018089 Anti-CD73 antibodies and uses thereof

Patent 12018089 was granted and assigned to Incyte on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Juan Carlos Almagro0

Rebecca A. Buonpane0

Shaun M. Stewart0

Jing Zhou0

Horacio G. Nastri0

Date of Patent

June 25, 2024

0

Patent Application Number

171382790

Date Filed

December 30, 2020

0

Patent Citations

US Patent 10100129 Antibodies against CD73 and uses thereof

0

US Patent 9090697 Methods for treating bleeding disorders

0

US Patent 9388249 Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same

0

US Patent 9605080 Antibodies against CD73

0

US Patent 9938356 Binding molecules specific for CD73 and uses thereof

0

US Patent 10287362 Binding molecules specific for CD73 and uses thereof

0

Patent Primary Examiner

Nelson B Moseley, II

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

Anti-CD73 antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, and pharmaceutical compositions. Methods of treating cancer with the anti-CD73 antibodies are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12018089 Anti-CD73 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool